Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Times Interest Earned (2014)

Minerva Neurosciences' (NERV) quarterly Times Interest Earned came in at -$1.02 in Q1 2026, up 73.88% on a QoQ basis from -$3.92 in Q4 2025.

Analysis

Minerva Neurosciences (NERV) Times Interest Earned (2014) Analysis & Trends

Minerva Neurosciences (NERV) has 14 years of Times Interest Earned data on file, last reported at -$1.02 in Q1 2026.

  • Quarterly Times Interest Earned changed N/A year-over-year to -$1.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.71 (changed N/A YoY) and the FY2025 annual result came in at -$0.15, up 33.38% from the prior year.
  • Times Interest Earned rose to -$1.02 in Q1 2026, from -$3.92 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$0.05 in Q4 2024 to a low of -$369.27 in Q2 2024.
  • A 5-year average of -$52.66 and a median of -$3.08 in 2023 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2022 — Times Interest Earned surged 78.09% — and 2024, when it plunged 16419.07%.
  • Tracing NERV's Times Interest Earned over 5 years: stood at -$0.06 in 2022, then plunged by 31.6% to -$0.07 in 2023, then jumped by 36.41% to -$0.05 in 2024, then slumped by 8231.74% to -$3.92 in 2025, then soared by 73.88% to -$1.02 in 2026.
  • The last three Times Interest Earned figures came in at -$1.02 (Q1 2026), -$3.92 (Q4 2025), and -$0.05 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Minerva Neurosciences 207.37 Mn 207.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -10.22